Skip to content

Find our latest news, stories and insights

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Catch up on the latest press releases and download media assets here

  1. Home/
  2. Impact Ventures /
  3. SwipeRx boosts Series B to US$37 Million to accelerate its B2B pharmacy platform across Southeast Asia

SwipeRx boosts Series B to US$37 Million to accelerate its B2B pharmacy platform across Southeast Asia

  • This new round marks an investment from marquee investors such as global pharma Sanofi’s Global Health Unit and Cercano (formerly Microsoft co-founder Paul Allen’s Vulcan Capital) with strong participation from existing investors.
  • Fresh funds to be deployed towards expanding Business to Business (B2B) commerce for pharmacies, investing in specialised healthcare logistics and financing and accelerating adoption of its new point of sale and inventory management solutions.
  • SwipeRx will further grow its current network of over 250,000+ pharmacy professionals and 50,000+ pharmacies in Southeast Asia. 1 in every 3 pharmacists in Southeast Asia is on SwipeRx.

Read the full article on the SwipeRx website.

Impact Ventures is an investment fund within the J&J Foundation, supporting a global portfolio of early-stage companies transforming access to quality and affordable healthcare.